Bacteria News and Research

RSS

New discovery reveals how immune 'sentinel' cells are maintained

WEHI researchers have made a surprise discovery about how immune 'sentinel' cells are maintained, which could have implications for drugs in development for treating cancer.

20 Sep 2021

Research on SARS-CoV-2 and dendritic cells may explain why virus is so virulent

In a recent study released on the bioRxiv* preprint server, the researchers suggest that an aberrant inflammatory reaction associated with COVID-19 could be a result of escape from direct sensing by toll-like receptors (TLRs). Moreover, the researchers indicate that this phenomenon might underlie the lack of efficient immunity to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early during infection.

20 Sep 2021

Pairing bacteriophages with antibiotics to fight drug-resistant pathogens

Mycobacterium abscessus, a relative of the bacteria that cause tuberculosis and leprosy, is responsible for particularly severe damage to human lungs and can be resistant to many standard antibiotics, making infections extremely challenging to treat.

18 Sep 2021

Increased presence of certain bacteria in the gut may indicate colon cancer risk

A study published today in the journal Cell Host & Microbe reported that the increased presence of certain bacteria in a gut biome indicates a greater likelihood that colon polyps will become cancerous.

18 Sep 2021

CDC to invest $2.1 billion to improve safety and quality of healthcare in the U.S.

Today, the Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control activities across the U.S. public health and healthcare sectors.

18 Sep 2021

Researchers take major step forward in the development of microbial fuel cells

A UCLA-led team of engineers and chemists has taken a major step forward in the development of microbial fuel cells - a technology that utilizes natural bacteria to extract electrons from organic matter in wastewater to generate electrical currents.

17 Sep 2021

Research could help design peptides to halt antibiotic-resistant bacteria

Peptides could be primed to solve the knotty problem of antibiotic resistance among humans. Rice University scientists believe they can help.

17 Sep 2021

Skin cancer patients could have better prognosis with stronger T cell receptor signal strength

New research led by the University of Birmingham suggests that skin cancer patients could have a better prognosis if their T cells send messages from five specific genes in their immune response to drugs given to treat the disease.

17 Sep 2021

Discovery of biological response platform could provide opportunity to alleviate allergic inflammation

New discoveries about a built-in rapid reaction system that triggers inflammatory responses when people are exposed to allergens, such as insects, mites, and fungi, also may hold the keys to helping more people manage their allergies in years to come.

17 Sep 2021

Study points to a possible new approach for treating MRSA superbug

A study released in STEM CELLS Translational Medicine, by researchers at the Baker Institute for Animal Health, part of Cornell University's College of Veterinary Medicine, Ithaca, N.Y., details in a relevant ex vivo model how treating wounds with the secretion of a type of stem cell called mesenchymal stromal cell (MSC) effectively reduced methicillin-resistant Staphylococcus aureus – better known as MRSA viability and stimulated the surrounding skin cells to build up a defense against the bacterial invader.

16 Sep 2021

UTSW researchers discover how vitamin A enters immune cells in the intestines

Immunologists and geneticists at UT Southwestern Medical Center have discovered how vitamin A enters immune cells in the intestines – findings that could offer insight to treat digestive diseases and perhaps help improve the efficacy of some vaccines.

16 Sep 2021

COVID-19 and the gut-lung axis

A new study explores the hypothesis that stimulation of the gut could be responsible for the lung inflammation seen in COVID-19, triggered by SARS-CoV-2.

16 Sep 2021

New study reveals chemical steps in an important cellular modification process

The chemical steps in an important cellular modification process that adds a chemical tag to some RNAs have been revealed in a new study. Interfering with this process in humans can lead to neuronal diseases, diabetes, and cancers.

16 Sep 2021

Pew announces support for the 2021 class of Innovation Fund investigators

The Pew Charitable Trusts announced today the six pairs of researchers who will make up its 2021 class of Innovation Fund investigators.

15 Sep 2021

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

In a recent study, researchers investigate the possibility of using the thiazolide antiparasitic nitazoxanide for the treatment of COVID-19.

15 Sep 2021

Researchers quantify the risk of children suffering severe outcomes from malaria

For the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford have quantified the risk of children suffering severe outcomes from malaria.

15 Sep 2021

Genetic capacity of the gut microbiome determines weight loss success or failure

The strongest associations with weight loss success or failure – independent of BMI – are found in the genetic capacity of the gut microbiome.

15 Sep 2021

Drug accumulation alters gut bacterial metabolism and composition

In a research paper recently published in the journal Nature by Klünemann et al. (September 8th, 2021), the interaction of 15 diverse drugs with 25 common strains of gut bacteria is investigated, revealing 70 bacteria-drug interactions that include 29 entirely novel mechanisms not yet reported.

15 Sep 2021

Blocking a specific immune cell could reverse antibiotic-induced breast cancer growth

Leading scientists have identified a possible link between antibiotic use and the speed of breast cancer growth in mice, and identified a type of immune cell that could be targeted to reverse it.

15 Sep 2021

Gut microbiome can help or confer resistance to weight loss

Gut microbiota influences the ability to lose weight in humans, according to new research. The findings were published this week in mSystems, an open-access journal of the American Society for Microbiology.

14 Sep 2021

Bacteria News and Research

New discovery reveals how immune 'sentinel' cells are maintained

Research on SARS-CoV-2 and dendritic cells may explain why virus is so virulent

Pairing bacteriophages with antibiotics to fight drug-resistant pathogens

Increased presence of certain bacteria in the gut may indicate colon cancer risk

CDC to invest $2.1 billion to improve safety and quality of healthcare in the U.S.

Researchers take major step forward in the development of microbial fuel cells

Research could help design peptides to halt antibiotic-resistant bacteria

Skin cancer patients could have better prognosis with stronger T cell receptor signal strength

Discovery of biological response platform could provide opportunity to alleviate allergic inflammation

Study points to a possible new approach for treating MRSA superbug

UTSW researchers discover how vitamin A enters immune cells in the intestines

COVID-19 and the gut-lung axis

New study reveals chemical steps in an important cellular modification process

Pew announces support for the 2021 class of Innovation Fund investigators

Phase I trial investigates using antiparasitic nitazoxanide for treatment of COVID-19

Researchers quantify the risk of children suffering severe outcomes from malaria

Genetic capacity of the gut microbiome determines weight loss success or failure

Drug accumulation alters gut bacterial metabolism and composition

Blocking a specific immune cell could reverse antibiotic-induced breast cancer growth

Gut microbiome can help or confer resistance to weight loss

Microbiology eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo